Appropriateness of the modality of revascularization according to the SYNTAX Score II 2020 in the FASTTRACK CABG study: An interim report on patient selection

Cardiovasc Revasc Med.

3 April Apr 2023 one year ago
  • Mushtaq S, Bartorelli AL, Pompilio G, Andreini D.

Personalized long term vital prognosis plays a key role in deciding between percutaneous coronary intervention (PCI) and CABG in patients with complex coronary artery disease. The FASTTRACK CABG trial enrolls patients with the sole guidance of coronary computed tomographic angiography (CCTA) and fractional flow reserve CCTA (FFRCT). The feasibility/non-feasibility of this approach is determined by the surgeon request to have access to the invasive coronary angiography.

Reference: Appropriateness of the modality of revascularization according to the SYNTAX Score II 2020 in the FASTTRACK CABG study: An interim report on patient selection.
Ninomiya K, Serruys PW, Garg S, Masuda S, Kageyama S, Kotoku N, Morel MA, Taylor C, Puskas JD, Narula J, Schneider U, Doenst T, Tanaka K, De Mey J, La Meir M, Mushtaq S, Bartorelli AL, Pompilio G, Andreini D, Onuma Y. Cardiovasc Revasc Med. 2023 Jan 9:S1553-8389(23)00001-5

Go to PubMed